Latest Headlines

Latest Headlines

Lilly, Novartis and Pfizer give trial-patient matching tech to TrialReach

Eli Lilly, Novartis and Pfizer have found a new home for the tech they created to improve ClinicalTrials.gov. The group is giving what it has achieved to date to TrialReach, a tech company developing a patient-focused clinical trial discovery platform.

TrialReach raises $13.5M to connect patients with studies

London startup TrialReach hauled in $13.5 million in Series B cash, funds that will help expand its technology designed to connect patients with their ideal clinical trials.

TrialReach raises $13.5M for clinical trial-patient matching service

TrialReach raised $13.5 million in a Series B round to scale up its clinical trial discovery platform. The system is designed to accelerate enrollment into clinical research by matching patients to appropriate trials.

TrialReach rounds up $1.2M for online trial recruitment

Sponsors and contract research outfits know all too well the pain of finding qualified patients for clinical research, as delays in recruitment can stall a program's development progress....